CTXR

CITIUS PHARMACEUTICALS INC

CTXR·17322U306·US·Common Stock·Healthcare - Biotechnology-13D/G

CTXR (CITIUS PHARMACEUTICALS INC) is held by 26 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($130,302), VANGUARD CAPITAL MANAGEMENT LLC ($119,405), CITADEL ADVISORS LLC ($75,508). Net institutional sentiment: Mixed.

26
Holders
(1 Elite)
$638,235
Total Value
56% (25)
Consensus
14 buying - 11 selling
13F: Insider & Congress: Updated regularly
CTXR

Smart Money Verdict

View all
Loading verdict
Held by 26 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistCICVI Investments, Inc.9.9%Aug 14, 2026
ActivistCICVI Investments, Inc.9.9%Feb 17, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
215,537(-12.4%)$130,3020.0%-94.86%
0
Increased
197,364(+17.7%)$119,4050.0%-19.81%
18
New
124,910$75,5080.0%-4.61%
33
Increased
122,837(+445.4%)$74,2550.0%-16.86%
23
Unchanged
77,755$47,0420.0%-22.01%
0
Decreased
69,850$42,2240.0%-85.24%
0
Increased
62,742(+42.7%)$37,9280.0%-92.94%
18
Increased
59,199(+178.0%)$35,7860.0%-18.50%
32
Decreased
26,335(-52.1%)$15,9330.0%-50.77%
0
Increased
25,445(+1.6%)$15,3810.0%-25.75%
12
Unchanged
23,271$14,0670.0%-96.95%
0
Increased
17,494(+33.2%)$10,5750.0%-35.86%
15
New
11,810$7,1390.0%-4.61%
25
Decreased
11,795(-68.0%)$7,1300.0%-37.96%
0
Decreased
2,575(-5.8%)$1,5430.0%-94.18%
0
New
1,551$9380.0%-4.61%
17
New
1,256$7590.0%-4.61%
17
New
1,096$6630.0%-4.61%
17
New
1,000$6050.0%-4.61%
17
New
1,000$6050.0%-4.61%
17

Showing 1-20 of 31

1 / 2
CTXRCTXRCITIUS PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used